LEADER 01587nam  2200385 a 450 
001 9910702154103321
005 20120926111620.0
035   $a(CKB)5470000002424597
035   $a(OCoLC)811138992
035   $a(EXLCZ)995470000002424597
100   $a20120926d2012      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGeneral principles for the use of pharmacological agents to treat individuals with co-occurring mental and substance use disorders$b[electronic resource]
210  1$a[Washington, D.C.] :$cU.S. Dept. of Health and Human Services, Substance Abuse and Mental Health Services Administration,$d[2012]
215   $a1 online resource (15 pages)
225 1 $aHHS Publication ;$vno. SMA-12-4689
300   $aTitle from title screen (viewed on Sept. 26, 2012).
320   $aIncludes bibliographical references (pages 10-12).
606   $aPsychopharmacology$zUnited States
606   $aDrug abusers$xRehabilitation$zUnited States
606   $aMental health$xTreatment$zUnited States
615  0$aPsychopharmacology
615  0$aDrug abusers$xRehabilitation
615  0$aMental health$xTreatment
712 02$aUnited States.$bSubstance Abuse and Mental Health Services Administration.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910702154103321
996   $aGeneral principles for the use of pharmacological agents to treat individuals with co-occurring mental and substance use disorders$93165631
997   $aUNINA